May 12, 2023
Ken Ishitani, Executive Director, Japan Association of Obstetricians and Gynecologists Linepharma’s Mefeego (mifepristone/misoprostol) was approved last month as Japan’s first oral abortion drug, but OB/GYNs think its initial uptick would be slow due to stringent facility requirements. They see its...read more